Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.004 AUD | 0.00% | 0.00% | +14.29% |
25/03 | Avecho Biotechnology Begins Patient Recruitment for Phase Three Anti-Insomnia Drug Trial | MT |
14/03 | Avecho to Push Forward with Phase III Trial of Anti-Insomnia Drug | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
+14.29% | 8.29M | |
+23.48% | 48.09B | |
+46.90% | 40.62B | |
-3.17% | 40.43B | |
-6.20% | 28.36B | |
+8.97% | 24.89B | |
-20.17% | 19.01B | |
+28.49% | 12.09B | |
+0.54% | 11.88B | |
-1.06% | 11.8B |
- Stock Market
- Equities
- AVE Stock
- News Avecho Biotechnology Limited
- Avecho Biotechnology Signs Development Deal for TPM-enhanced Ibuprofen Gel for US market; Shares Up 10%